Evidence map›Paper›PMID 35621029›Full record

ArticleDiabetic medicine : a journal of the British Diabetic Association2022

Management of type 1 diabetes in low- and middle-income countries: Comparative health system assessments in Kyrgyzstan, Mali, Peru and Tanzania.

Aida Abdraimova, Stéphane Besançon, Jill Portocarrero, Kaushik Ramaiya, Asel Dunganova, Margaret Ewen, Hans Hogerzeil, Maria Lazo-Porras, Richard Laing, Molly Lepeska and 8 more

Abstract read
In one paragraph

Article in Diabetic medicine : a journal of the British Diabetic Association, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Aida AbdraimovaHealth Policy Analysis Centre, Bishkek, Kyrgyzstan.
Stéphane BesançonSanté Diabète, Bamako, Mali.
Jill PortocarreroCRONICAS Centre of Excellence in Chronic Diseases, Universidad Peruana Cayetano Heredia, Lima, Peru.
Kaushik RamaiyaHindu Mandal Hospital, Dar es Salaam, Tanzania.
Asel DunganovaHealth Policy Analysis Centre, Bishkek, Kyrgyzstan.
Margaret EwenHealth Action International, Amsterdam, The Netherlands.
Hans HogerzeilUniversity Medical Centre, Groningen, Netherlands.
Maria Lazo-PorrasCRONICAS Centre of Excellence in Chronic Diseases, Universidad Peruana Cayetano Heredia, Lima, Peru.ORCID 0000-0003-0062-5476
Richard LaingBoston University School of Public Health, Boston, USA.
Molly LepeskaHealth Action International, Amsterdam, The Netherlands.
Happy NchimbiTanzanian NCD Alliance, Dar es Salaam, Tanzania.
Assa SidibéHôpital du Mali, Bamako, Mali.
Andrew SwaiTanzanian Diabetes Association, Dar es Salaam, Tanzania.
Janeth Tenorio-MuchaCRONICAS Centre of Excellence in Chronic Diseases, Universidad Peruana Cayetano Heredia, Lima, Peru.
John S YudkinDivision of Medicine, University College London, London, UK.
Jessica H Zafra-TanakaCRONICAS Centre of Excellence in Chronic Diseases, Universidad Peruana Cayetano Heredia, Lima, Peru.ORCID 0000-0001-6386-6643
Aida ZurdinovaMinistry of Health, Bishkek, Kyrgyzstan.
David BeranDivision of Tropical and Humanitarian Medicine, University of Geneva and Geneva University Hospitals, Geneva, Switzerland.ORCID 0000-0001-7229-3920

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsTo describe and compare the health system responses for type 1 diabetes in Kyrgyzstan, Mali, Peru and Tanzania.

methodsThe Rapid Assessment Protocol for Insulin Access, a multi-level assessment of the health system, was implemented in Kyrgyzstan, Mali, Peru and Tanzania using document reviews, site visits and interviews to assess the delivery of care and access to insulin.

resultsDespite the existence of noncommunicable or diabetes strategies and Universal Health Coverage policies including diabetes-related supplies, this has not necessarily translated into access to insulin or diabetes care for all. Insulin and related supplies were often unavailable and unaffordable. Across the four countries test strips and insulin, when paid for by the individual, represented respectively 48-82% and 25-36% of total costs. Care was mainly delivered at tertiary-level hospitals by specialists. Only Kyrgyzstan had data collection systems integrated into the Ministry of Health structure. In addition, issues with healthcare worker training and education and empowerment of people with diabetes were present in these health systems.

conclusionsPeople with type 1 diabetes in these countries face different barriers, including the cost of insulin and care. Given the renewed attention to diabetes on the global health agenda tailored health system responses for type 1 diabetes are needed. Insulin should be prioritized as it is the foundation of type 1 diabetes care, but other elements of care and support need to be fostered by different actors.

Indexed as

Diabetes Mellitus, Type 1Developing CountriesHumansInsulinKyrgyzstanMaliPeruTanzaniaInsulindeveloping countrieshealth delivery of health careinsulintype 1 diabetes

Identifiers

PMID35621029
PMCPMC9543552

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.